Neurocognitive deficits associated with the hepatitis C virus among incarcerated men

Clinical Neuropsychologist

Volumn 27, Issue 3, 2013, Pages 426-436

  Umaki, Tracie M ^a,b   Denney, Robert L ^b,c  

^a UNIVERSITY OF HAWAII   (United States)

^b Forest Institute of Professional Psychology   (United States)

^c US Medical Center for Federal Prisoners Springfield   (United States)

Author keywords

Assessment; Attention: Executive functions; Infectious disease; Non HIV

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PSYCHOLOGICAL ASPECT; RECALL; VERBAL BEHAVIOR; VIROLOGY;

ADULT; COGNITION DISORDERS; HEPATITIS C; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; STATISTICS, NONPARAMETRIC; VERBAL BEHAVIOR;

EID: 84876686656     PISSN: 13854046     EISSN: 17444144     Source Type: Journal    
DOI: 10.1080/13854046.2012.758315     Document Type: Article

References (40)

1. Adams, K. M., Brown, G. G., & Grant, I. (1985). Analysis of covariance as a remedy for demographic mismatch of research subject groups: Some sobering simulations. Journal of Clinical Experimental Neuropsychology, 7, 445-462.
2. Allen, S., Rich, J. D., Schwartzapfel, B., & Friedmann, P. D. (2003). Hepatitis C among offenders: Correctional challenge and public health. Federal Probation, 67, 22-26.
3. Alper, B. S., & Selius, B. A. (2005). Hepatitis C. Cortlandt Forum, 7, 59-60.
4. Baker, L. J., & Welkowitz, L. A. (2005). Asperger's syndrome: Intervening in schools, clinics, and communities. Mahwah, NJ: Lawrence Erlbaum Associates Inc.
5. Bieliauskas, L. A., Back-Madruga, C., Lindsay, K. L., Snow, K. K., Kronfol, Z., Lok, A. S., Fontana, R. J. (2006). Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis. Journal of Clinical and Experimental Neuropsychology, 28, 1346-1361.
6. Byrnes, V., Miller, A., Lowry, D., Hill, E., Weinstein, C., Alsop, D., Afdhal, N. H. (2012). Effects of antiviral and HCV clearance on cerebral metabolism and cognition. Journal of Hepatology, 56, 549-556.
7. Center for Disease Control and Prevention. (2003). Prevention and control of infection with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report, 52(RR-1), 1-34. Retrieved from http://www.cdc.gov
8. Center for Disease Control and Prevention. (2011). Hepatitis C and incarceration (Publication No. 21-1306). Retrieved from http://www.cdc.gov
9. Chen, S., & Morgan, T. M. (2006). The natural history of Hepatitis C virus (HCV) infection. International Journal of Medical Science, 3, 47-52.
10. Collie, A. (2005). Cognition in liver disease. Liver International, 25, 1-8.
11. Cordoba, J., Flavia, M., Jacas, C., Sauleda, S., Esteban, J. I., Vargas, V., Guardia, J. (2003). Quality of life and cognitive function in hepatitis C at different stages of liver disease. Journal of Hepatology, 39, 231-238.
12. Devlin, K. N., Gongvatana, A., Clark, U. S., Chasman, J. D., Westbrook, M. L., Tashima, K. T., et al. (2012). Neurocognitive effects of HIV, hepatitis C, and substance use history. Journal of International Neuropsychological Society, 18, 1-11.
13. Fontana, R. J., Bieliauskas, L. A., Back-Madruga, C., Lindsay, K. L., Kronfol, Z., Lok, A. S., HALT-C Trial Group. (2005). Cognitive function in hepatitis C patients with advanced fibrosis enrolled in Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial. Journal of Hepatology, 43, 614-622.
14. Forton, D. M., Allsop, J. M., Cox, J., Hamilton, G., Wesnes, K., Thomas, H. C., & Taylor-Robinson, S. D. (2005). A review of cognitive impairments and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, 19(suppl. 3), S53- S63.
15. Forton, D. M., Allsop, J. M., Main, J., Foster, G. R., Thomas, H. C., & Taylor-Robinson, S. D. (2001). Evidence for a cerebral effect of the hepatitis C virus. The Lancet, 358, 38-39.
16. Forton, D. M., Hamilton, G., Allsop, J. M. Grover, V. P., Wesnes, K., O'Sullivan, C., Taylor-Robinson, S. D. (2008). Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. Journal of Hepatology, 49, 316-322.
17. Forton, D. M., Taylor-Robinson, S. D., & Thomas, H. C. (2003). Cerebral dysfunction in chronic hepatitis C infection. Journal of Viral Hepatitis, 10, 81-86.
18. Forton, D. M., Taylor-Robinson, S. D., & Thomas, H. C. (2006). Central nervous system changes in hepatitis C virus infection. European Journal of Gastroenterology and Hepatology, 18, 333-338.
19. Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Taylor-Robinson, S. D. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35, 433-439.
20. Green, P. (2003). Medical Symptom Validity Test manual. Edmonton, AB: Green's Publishing.
21. Grover, V. P. B., Pavese, N., Koh, S. B., Wylezinska, M., Saxby, B. K., & Gerhard, A. (2012). Cerebral microglial activation in patients with hepatitis C: In vivo evidence of neuroinflammation. Journal of Viral Hepatitis, 19, c89- c96.
22. Hilsabeck, R. C., Anstead, G. M., Webb, A. L., Hoyumpa, A., Ingmundson, P., Holliday, S., Stern, S. L. (2010). Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. Journal of Neuroimmunology, 221, 53-61.
23. Hilsabeck, R. C., Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003). Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. Journal of the International Neuropsychological Society, 9, 847-854.
24. Hilsabeck, R. C., & Malek-Ahmadi, P. (2004). Neurobehavioral correlates of chronic hepatitis C. Journal of Psychopathology and Behavioral Assessment, 26, 203-210.
25. Hilsabeck, R. C., Perry, W., & Hassanein, T. I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35, 440-446.
26. Lezak, M., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York, NY: Oxford University Press.
27. McAndrews, M. P., Farcnik, K., Carlen, P., Damyanovich, A., Mrkonjic, M., Jones, S. Heathcote, E. J. (2005). Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology, April, 801-808.
28. Merck manual. (2006). Manual home edition. Retrieved October 29, 2006, from: http://www. merck.com/mmhe
29. Mooney, S., Hassanein, T. I., Hilsabeck, R. C., Ziegler, E. A., Carlson, M., Maron, L. M., UCSD Hepatology Neurobehavioral Research Program (2007). Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant. Archives of Clinical Neuropsychology, 22, 175-186.
30. Morgan, G. A., Leech, N. L., Gloeckner, G. W., & Barrett, K.C. (2004). SPSS for introductory statistics: Use and interpretation (second edition). Mahwah, NJ: Lawrence Erlbaum Associates Inc.
31. Perry, W., Carlson, M. D., Barakat, F., Hilsabeck, R. C., Schiehser, D. M., Matthews, C., & Hassanein, T. I. (2005). Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS, 19(suppl 3), S79- S84.
32. Perry, W., Hilsabeck, R. C., & Hassanein, T. I. (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases and Sciences, 53, 307-321.
33. Randolph, C. (1998). Repeatable Battery for the Assessment of Neuropsychological Status, manual. San Antonio, TX: The Psychological Corporation.
34. Sheth, S. G., Flamm, S. L., Gordon, F. D., & Chopra, S. (1998). AST/ALT ratio predicts cirrhosis in patients with hepatitis C virus infection. American Journal of Gastroenterology, 93, 44-48.
35. Sorrell, J. H., Zolnikov, B. J., Sharma, A., & Jinnai, I. (2006). Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplant. Psychiatry and Clinical Neurosciences, 60, 174-181.
36. Taylor, M. J., Letendre, S. L., Schweinsburg, B. C., Alhassoon, O. M., Brown, G. G., Gongvatana, A., et al. (2004). Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. Journal of the International Neuropsychological Society, 10, 110-113.
37. Thein, H. H., Maruff, P., Krahn, M. D., Kaldor, J. M., Koorey, D. J., Brew, B. J., & Dore, G. J. (2007). Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Medicine, 8, 520-528.
38. Weinbaum, C., Lyerla, R., & Margolis, H. S. (2003). Prevention and control of infection with hepatitis viruses in correctional settings, Center for Disease Control. Morbidity and Mortality Weekly Report 52 (RR-1), 1-34.
39. Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schuler, A., Ennen, J. C., Böker, K. W. (2004). Hepatitis C virus infection affects the brain - evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 21, 845-851.
40. Zachary, R. A. (1988). Shipley Institute of Living Scale. Los Angeles, CA: Western Psychological Services.